Genomma Lab Internacional SAB de CV wants to nominate five individuals to Prestige Brands Holdings Inc.’s board in a likely attempt to force the OTC drug and personal care product marketer to accept its hostile takeover bid of $834 million.
Genomma announced March 15 its intention to nominate a full slate of directors at PBH’s annual meeting of shareholders June 29 after Prestige Brands on March 12 rejected its unsolicited...